FDA Approved Medical Products for:

Renal cell carcinoma 4

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Sorafenib
Trade Name
(Manufacturer Name)
Nexavar
(Bayer HealthCare Pharmaceuticals)
Indication
The FDA has approved this product to be used in this manner.
Treatment of patients with advanced renal cell carcinoma

Generic Name Sorafenib
Trade Name
(Manufacturer Name)
Nexavar®
(Bayer HealthCare Pharmaceuticals)
Indication
The FDA has approved this product to be used in this manner.
Treatment of patients with advanced renal cell carcinoma
More Information about this product Drug Information Portal

Generic Name Aldesleukin
Trade Name
(Manufacturer Name)
Proleukin®
(Novartis)
Indication
The FDA has approved this product to be used in this manner.
Treatment of adults (>18 years old) with metastatic renal cell carcinoma.
More Information about this product Drug Information Portal
Medline Plus Health Information

Generic Name Temsirolimus
Trade Name
(Manufacturer Name)
Torisel®
(Wyeth Pharmaceuticals, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of advanced renal cell carcinoma
More Information about this product Drug Information Portal
Medline Plus Health Information